A myxoid fibrotic reaction pattern is associated with metastatic risk in cutaneous squamous cell carcinoma by Hernandez Ruiz, Maria Eugenia et al.
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SIGNIFICANCE
Cutaneous squamous cell carcinomas are the second most 
frequent non-melanoma skin cancers. Despite their gene-
rally good prognosis, approximately 2–5% metastasize, 
usually to regional lymph nodes. Recent works have elu-
cidated the relevance of the tumour microenvironment, 
consisting of a stromal reaction, a vascular and lymphatic 
network and the presence of specific inflammatory cell 
subpopulations, in the development of metastases. In this 
study we have characterized different types of stromal 
reaction patterns in cutaneous squamous cell carcinoma, 
including desmoplasia, and have found that the presence 
of a myxoid peritumoral infiltration, easily recognisable by 
hematoxylin eosin stains, is associated with an increased 
metastatic risk.
Although desmoplasia has been associated with poor 
prognoses in cutaneous squamous cell carcinoma, little 
attention has been paid to the patterns of fibrosis. This 
study aimed to examine the different stromal fibrotic 
patterns as markers of metastatic risk. We performed 
a multicenter retrospective study that included 102 cu-
taneous squamous cell carcinomas (52 non-metastatic 
and 50 metastatic carcinomas). Clinical and histopa­
thological data were registered. The fibrotic reaction 
pattern was classified as mature, intermediate or im-
mature depending on the presence of keloid-like colla-
gen and myxoid stroma. The immature pattern (areas 
characterized by myxoid changes with no inflamma-
tion) was observed in 18 samples and its presence was 
significantly associated with immuno suppression, bud-
ding, desmoplasia, perineural invasion, anatomic level, 
tumoural depth and metastatic risk in the multivariate 
analysis. Our findings suggest that the presence of an 
immature myxoid fibrotic pattern, which can be easily 
identified by routine hematoxylin­eosin staining, is 
strongly associated with metastatic risk.
Key words: metastasis; fibrosis; cutaneous squamous cell car-
cinoma. 
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Metastatic cutaneous squamous cell carcinomas (MSCCs) usually involve the regional lymph 
nodes, and occur in approximately 4–5% of patients (1). 
Active research in cutaneous SCC (cSCC) is aimed at the 
identification of prognostic markers of clinical value that 
could help identify those patients at higher metastatic risk. 
Prominent clinical factors linked to an aggressive clinical 
behaviour and metastatic risk include tumoural size, im-
munosuppression and certain tumour locations such as the 
ears, lips and areas of chronic injury. Some histological 
parameters of the primary tumour, including depth, poor 
histological differentiation and perineural invasion have 
also been associated with poor prognosis (2–4).
Epithelial to mesenchymal transition (EMT), a me-
chanism by which epithelial cells lose adhesion and 
acquire mesenchymal traits that allow them to invade 
and disseminate (5), has been shown to be involved in 
the metastasis of a variety of epithelial tumours. Indeed, 
we have previously reported that the presence of EMT 
markers is associated with an increased metastatic risk in 
cSCC (6). Tumour budding, pathologically characterized 
by clusters or single tumoural cells that may reflect cells 
undergoing EMT, has also been recently linked to nodal 
metastasis in cSCC (7, 8). 
The EMT process can be induced by the tumoural 
microenvironment through the release of cytokines 
and extracellular matrix proteins by cancer-associated 
fibroblasts (CAFs). In addition to their effect on epi­
thelial tumoural cells, CAFs may also generate a fibro-
tic stroma. The role of the fibrotic reaction in cancer 
development and progression remains controversial. 
While some studies suggest that the host may favour a 
desmoplastic response to limit tumour aggressiveness 
(9), others have shown that the fibrotic stroma induced 
by CAFs might benefit the tumour by inhibiting access 
to immune cells (10–13). In this sense, the association 
between desmoplastic reaction and poor outcome has 
been observed in several cancers such as cholangiocar-
cinoma, breast, pulmonary, pancreatic, tongue, rectal 
and colorectal carcinomas (11, 14–18). cSCC with a 
desmoplastic phenotype, characterized by strands and 
nests of tumour cells surrounded by a prominent fibrous 
stromal response, may also pose an increased risk of 
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recurrence and metastases (3, 19). Indeed, the presence 
of desmoplasia is considered to be a high­risk factor 
by the NCCN and the European Dermatology Forum, 
the European Association of Dermato-Oncology, and 
the European Organization for Research and Treatment 
of Cancer (EDF­EADO­EORTC) guidelines (20, 21). 
Unlike other carcinomas, such as rectal and colorectal 
cancers (17, 18), little attention has been given to the 
study of fibrotic patterns and their correlation with bio-
logical behaviour in cSCC. In this study, we aimed to 
study the association between different fibrotic patterns 
and lymphatic metastatic risk in cSCC.
PATIENTS AND METHODS
Patients
Cutaneous biopsies from patients presenting cSCC from 3 tertiary 
hospitals in Spain between 2001 to 2011 were included in the study. 
Selected biopsies corresponded either to primary cSCC tumours of 
patients who had developed metastatic spread (MSCC) or to cSCC 
without an aggressive clinical behaviour after a long follow-up 
period (NMSCC). Fifty primary MSCC with lymph node (n = 40) 
and/or cutaneous in-transit metastases (n = 10) were included in 
the study. Additionally, 52 cutaneous SCCs that had not developed 
metastatic spread after at least a 5-year follow-up period (NMSCC) 
were also evaluated as a control group.
A set of clinical data were retrospectively collected from each 
patient including sex, age, immunosuppression status and cause of 
immunosuppression, year of diagnosis, recurrences, tumour size 
and location. TNM staging evaluation by two systems (AJCC-8 
and Brigham and Women´s Hospital – BWH) (22, 23) was recor-
ded from each patient. 
Ethics approval was obtained from all the participating centers, 
in accordance with the guidelines of the Helsinki Declaration of 
1975, as revised in 1983. 
Histologic parameters
Following a systematized protocol, the following histopathological 
data were evaluated in all samples in H&E-stained glass slides: 
thickness (in mm), level of invasion, degree of differentiation 
(well, moderate, poor), presence of vascular or perineural invasion 
and, when present, the diameter of the affected nerve (in mm). 
Tumoural budding and fibrotic stroma were simultaneously 
evaluated by two of the authors (AT and MEH), who were blind 
to the aggressiveness of the tumours.
Fibrotic stroma. Desmoplasia was defined as the presence of small 
tumoural nests surrounded by stromal fibrosis in at least one third 
of the tumoural sample. 
The fibrotic reaction pattern (FRP) was evaluated at the ad-
vancing edge of the tumour by H&E and classified into one of 
3 categories (mature, intermediate, or immature) as previously 
reported (18), depending on the presence of keloid­like collagen 
and myxoid stroma. Keloid­like collagen was defined as the pre-
sence of bundles of hypocellular collagen and bright eosinophilic 
hyalinization. Myxoid stroma showed an amorphous stromal sub-
stance with an extracellular amphophilic or basophilic material. 
The presence of a myxoid or keloidal stroma was considered when 
observed with the 40x objective lens in areas with scarce or no 
inflammatory infiltrate. 
FRP was considered mature (mFR) when the fibrotic stroma 
lacked a keloid­like collagen or myxoid stroma and contained 
mature collagen fibres stratified into an onion­like pattern (Fig. 1). 
Intermediate fibrotic reaction was designated for tumours showing 
keloid­like fibrosis intermingled in mature stroma, while immature 
fibrosis (iFR) was assigned to tumours showing areas of myxoid 
changes with or without keloidal fibrosis (Fig. 2). The more im-
mature fibrotic areas were considered for analysis. 
A quantitative evaluation of the FRP was also performed. The 
area of fibrosis (percentage) surrounding the advancing edge of the 
tumour was recorded. The width of the fibrotic reaction was also 
categorised from 0 to 3 as follows: 1: 0–100 µm; 2: 100–200 µm; 
3: > 200 µm. A fibrosis burden score (area x width: 0–300) for 
fibrosis was calculated. 
Tumour budding. Tumour budding was defined based on the num-
ber of foci of isolated cancer cells or on the presence of a cluster 
comprising < 5 cells in the invasive frontal region, as previously 
reported (24). Cases with 5 or more foci, identified using a 40x 
objective lens, were regarded as positive for budding.
Stainings and immunohistochemistry. Alcian blue stainings were 
performed in cases showing a myxoid pattern in the H&E stain, 
in order to detect mucin deposition. To this end, slides were de-
paraffinized and hydrated. They then were stained with Alcian 
blue solution (1% Alcian Blue in 3% acetic acid solution, pH 
2.5) for 30 min and rinsed with water. Slides were counterstained 
with hematoxylin for 5 min, dehydrated and mounted with DPX.
For immunohistochemistry, slides were deparaffinized, hydrated 
and antigen retrieval was performed in 10 mM citrate (pH 6) for 
10 min in a pressure cooker (for α–SMA) or with Proteinase K 
15 min at 37ºC (for fibronectin). Tissues were then quenched for 
Fig. 1. Mature fibrotic reaction pattern (arrow) (H&E 40x).
Fig. 2. Immature fibrotic reaction pattern with myxoid (asterisks) 
and keloidal areas (arrow) (H&E 40x).
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
91Myxoid pattern in cutaneous squamous cell carcinoma
Acta Derm Venereol 2019
endogenous peroxidase activity with 4% (vol/vol) H2O2 for 10 
min at room temperature, blocked and incubated with primary 
antibodies overnight at 4°C. After washing, Envision+System-
HRP antibody reagent was applied Dako (Agilent Technologies). 
Immunohistochemical reactions were developed using diami-
nobenzidine (DAB) as a chromogenic substrate. Sections were 
counterstained with hematoxylin, dehydrated and mounted. The 
following antibodies were used: α­SMA from Sigma (A2547) and 
Fibronectin from Dako (A0245).
Statistical analyses
Correlations between categorical variables were evaluated using 
χ2 test or Fisher’s exact test when appropriate. Continuous data 
were compared using a Student’s t-test if the sample distribution 
was normal, or otherwise via a Mann-Whitney U-test. 
A multivariate logistic regression analysis was performed to 
determine which clinico-pathological features were predictive 
of lymphatic metastases. p < 0.05 was considered statistically 
significant. Analysis was conducted with SPSS 18.0 (SPSS Inc., 
Chicago, IL, USA).
RESULTS
Biopsy specimens (n = 102) from a total number of 102 
patients were included in the study (Table I). Fifty pa-
tients presented MSCC, 40 of them to the regional lymph-
nodes and 10 showing cutaneous in-transit satellitosis. 
More than half of the patients were men (69.6 %), and 
the median age was 79 years (Q1: 72; Q3: 85). Most of 
the cSCC were excised from sun-exposed areas, mainly 
the head and neck (85 cSCC), followed by extremities 
(14 cSCC) and trunk (3 cases). Twelve patients were im-
munosuppressed (8 kidney recipients, 1 hepatic recipient, 
1 Crohn’s disease, 1 chronic lymphatic leukemia and 1 
patient undertaking mycophenolate to treat glomerulo-
nephritis). Twelve cases involved recurrences.
In the whole data set, 36 patients had mFR whereas 18 
had iFR. Only 3 cases showed an intermediate fibrotic 
pattern. Recurrent cSCC presented mFR and iFR equally. 
Budding was observed in 34 of 50 MSCC (68%) and 
18 of 52 NMSCC (34.6%; p < 0.01). The iFR pattern 
was observed in 16 of 50 MSCC (32%) and in 2 of 52 
NMSCC (3.8%; p < 0.01). Unlike mFR, iFR was mostly 
observed in isolated foci and in surrounding budding 
areas (Figs 3a and 4). 
Although iFR mostly surrounded the budding areas 
(89% of the cases with myxoid changes), only 30.7% of 
tumours with budding had an associated iFR pattern. In-
terestingly, while budding showed a sensitivity superior 
Table I. Clinical and histopathological variables. Univariate analysis 
for metastatic risk
NMSCC 
(n = 52)
MSCC 
(n = 50) p
Clinical variables, n (%)
Area 
  Head
  Trunk
  Extremities
42 (80.8)
  1 (1.9)
  9 (17.3)
43 (86)
  2 (4)
  5 (10)
NS
Sun exposure, Yes 47 (94) 45 (90) NS
Horizontal size > 20 mm 20 (38.5) 19 (41.3) NS
Recurrent case, Yes   2 (3.8) 10 (20.4) 0.013
Immunosuppression, Yes   6 (11.5)   6 (13) NS
Pathological variables
Differentiation, n (%) 
  Good 
  Moderate
  Poor 
21 (40.4)
28 (53.8)
  3 (5.8)
  7 (14)
35 (70)
  8 (16)
< 0.01
Tumour thickness > 6 mm, n (%) 10 (19.2) 22 (47.8) < 0.01
Clark level ≥ 4, n (%) 35 (67.3) 44 (93.6) < 0.01
Perineural invasion, Yes, n (%)   1 (1.9)   8 (16) 0.015
Nerve diameter ≥ 0.1 mm, n (%)   0 (0)   7 (14) < 0.01
Vascular invasion, Yes, n (%)   0 (0)   2 (4) NS
Desmoplasia, Yes, n (%)   1 (1.9)   3 (6) NS
Budding, Yes, n (%) 18 (34.6) 34 (68) < 0.01
Mature fibrosis, n (%) 18 (34.6) 18 (36) NS
Intermediate fibrosis pattern, Yes, n (%)   0 (0)   3 (6) NS
Myxoid fibrosis, Yes, n (%)   2 (3.8) 16 (32) < 0.01
Fibrosis burden, median (IQR)   0 (0;135) 40 (0;160) 0.036
Staging systems, n (%)
TNM (AJCC-8)
  pT1
  pT2
  pT3
  pT4
25 (48,1)
14 (26.9)
13 (25)
  0 (0)
12 (25.5)
  6 (12.8)
26 (55.3)
  3 (6.4)
< 0.01
TNM (Brigham)
  1
  2a
  2b
  3
25 (48.1)
23 (44.2)
  4 (7.7)
  0 (0)
10 (21.7)
23 (50)
  9 (19.6)
  4 (8.7)
< 0.01
NMSCC: Nonmetastatic cutaneous squamous cell carcinoma; MSCC: Metastatic 
cutaneous squamous cell carcinoma; IQR: interquartile range.
Fig. 3. a) Immature fibrotic reaction pattern with myxoid peritumoral areas segregating an inflammatory infiltrate (H&E 40x). b) Alcian blue 
showing a larger stain around the tumour (arrow) (40x).
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to iFR in predicting aggressiveness (68% vs 32%), iFR 
showed a better specificity (96.2% vs 65.4%). 
In an attempt to better characterize the stromal fibro-
blasts, we carried out α­SMA staining, though positivity 
was only detected in 2 cases with iFR (Fig. 5). In contrast, 
increased expression of mucopolysaccharides (stained 
with Alcian blue) and fibronectin was frequently observed 
in areas with a myxoid reaction pattern, al though this was 
not restricted only to this pattern (data not shown) (Fig. 3b). 
Univariate analysis (Table I) revealed that previous 
recurrence, anatomic level (Clark ≥ 4), tumour thickness, 
budding, histological differentiation, myxoid stroma, 
peritumoural fibrosis burden and perineural invasion 
(and nerve diameter > 0.1) were significantly associated 
with metastasis development. Conversely, age, vascular 
invasion, desmoplasia and tumour size were not signi-
ficantly associated with metastatic risk. Both the AJCC 
and Brigham’s staging systems adequately classified 
both the MSCC and NMSCC groups, although the later 
proved to be more accurate.
Multivariate analysis, adjusted by age and sex, revea-
led that the myxoid stroma was the only independent 
factor associated with lymphatic metastases, with an odds 
ratio of 13.81 (95% confidence interval 1.70–112.01) 
(Table II). This pattern was associated with immunosup-
pression, budding, desmoplasia, perineural invasion, ana-
tomic level (Clark ≥ 4) and tumoural depth (Table III).
DISCUSSION
Analysis of fibrosis in cSCC has attracted little attention 
in the literature, with the exception of desmoplasia. This 
is in striking contrast with the widely reported association 
between fibrosis and poor prognosis in several cancers 
(11, 14–18, 25, 26. Fibrosis in cancer is induced by 
cancer­associated fibroblasts (CAFs) or myofibroblasts, 
which can induce EMT and cancer cell migration (27, 
28). Peritumoural fibrosis may favour tumoural progres-
sion by several mechanisms: driving integrin-dependent 
cell adhesion and migration, regulating tumour plasticity 
or by impairing tumour immunosurveillance. 
In the present work, we observed an association 
between fibrosis burden and metastatic risk in the uni-
Fig. 4. Immature fibrotic reaction pattern surrounding an area of 
tumoral budding. H&E 40x.
Fig. 5. a) Cutaneous squamous cell carcinoma with a myxoid reaction (H&E 40x) and b) α-SMA-expressing cells.
Table II. Univariate and multivariate analyses for metastatic risk 
Univariate analysis Multivariate analysis
ORrow CI 95% p ORadj CI 95% p
Clinical variables
Area 0.77 0.43–1.36 0.37
Sun exposure 0.57 0.13–2.55 0.47
Horizontal size > 2 cm 1.13 0.50–2.53 0.77 1.42 0.93–2.17 0.10
Recurrent case 6.41 1.33–30.96 0.02 3.88 0.38–39.42 0.25
Immunosuppression 1.15 0.34–3.85 0.82
Pathological variables
Differentiation 3.10 1.47–6.57 0.003 2.38 0.84–6.70 0.10
Tumour thickness ≥ 6 
mm
3.85 1.57–9.47 0.003 1.03 0.88–1.22 0.71
Clark level ≥ 4 7.12 1.93–26.28 0.003 2.55 0.49–13.22 0.26
Perineural invasion 9.71 1.17–80.82 0.035 6.45 0.39–107.49 0.19
Desmoplasia 3.26 0.33–32.39 0.31
Budding 4.01 1.76–9.15 0.001 2.77 0.68–11.3 0.16
Myxoid fibrosis 11.77 2.54–54.50 0.002 13.81 1.70–112.02 0.014
Fibrosis burden score 1.01 1.00–1.01 0.05 0.99 0.98–1.00 1.10
Staging systems
TNM (AJCC-8) 2.23 1.06–4.68 0.034
TNM (Brigham) 2 1.24–3.22 0.004
OR: odds ratio; CI: confidence interval; adj: adjusted. Bold: significant value.
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may not only trigger EMT, but also induce an excess of 
type 1 collagen deposition, as observed in the keloidal 
pattern (25). These observations suggest that a mucco-
polysaccharide-rich microenvironment may play a role 
in favouring EMT (budding), as well as in blocking the 
host immunological response, and therefore increasing 
the metastatic risk. 
We found areas of myxoid stroma to be easily detec-
ted by routine H&E staining in the advancing tumoural 
invasive front, even in poorly differentiated tumours. 
Conversely, we did not find α­SMA or fibronectin to 
increase the detection of this fibrotic pattern compared 
with H&E. Unlike previous studies, most areas of myx-
oid stroma in cSCC were devoid of α­SMA positivity, 
which may be due to several reasons: (i) fibrosis­inducing 
myofibroblasts are immature and do not express α­SMA; 
(ii) CAFs produce a muccopolysaccharide­rich stroma 
and thereby become nonessential; or (iii) myxoid-rich 
stroma is produced by a different cell.
In contrast to the myxoid pattern, we did not find any 
association between desmoplasia and metastatic risk in 
our series. Although there is some controversy about the 
definition of desmoplasia, many authors suggest that it 
confers tumoural growth and invasive advantages in 
cSCC (3, 19, 32). In the prospective study by Brantsch 
et al. (3), the local recurrence rate, but not the metastatic 
risk, was found to be higher in desmoplastic cSCC. In 
contrast, other authors have found this pattern to be as-
sociated with metastatic risk in cSCC (19, 24, 32). These 
heterogeneous results may reflect the lack of a common 
consensus in defining desmoplasia. 
There are several limitations in our report that should 
be stated. First, there are potential errors due to the re-
trospective nature of our study. Second, all of the centers 
that participated in the study are reference university 
hospitals that are more likely to receive previously treated 
and aggressive tumours. This may account for the high 
number of recurrent tumours among MSCC samples in 
our series (20.4%). 
In conclusion, we studied desmoplasia, the fibrotic 
burden and fibrosis patterns in a series of MSCC and 
NMSCC samples. Although fibrosis is a frequent finding 
in both aggressive and indolent tumours, our findings 
suggest that a myxoid pattern, together with an inflam-
matory exclusion (immature fibrotic pattern), is strongly 
associated with metastatic risk. Although it is perhaps 
premature to recommend the study of fibrotic patterns 
during routine examinations by pathologists, it is true that 
we all commonly observe that cSCC ending with small 
clusters or single tumoural cells, often surrounded by a 
stromal reaction, have a worse prognosis. This is due to 
the fact that these cells that can migrate and produce vas-
cular or neural invasions. Our work has focused on this 
aspect and we have found that is not only the presence of 
isolated tumoural cells that increases the metastatic risk, 
also known as tumour budding, but also the microenvi-
Table III. Univariate analysis for the presence of myxoid fibrosis
Myxoid fibrosis
Absence Presence p
Clinical variables, n (%)
Total 84 (82.3) 18 (17.6)
Area 
  Head
  Trunk
  Extremities
70 (83.3)
  2 (2.4)
12 (14.3)
15 (83.3)
  1 (5.6)
  2 (11.1)
NS
Sun exposure, Yes 76 (92.7) 16 (88.9) NS
Horizontal size > 20 mm 31 (38.8)   8 (44.4) NS
Recurrent case, Yes   8 (9.5)   4 (23.5) NS
Immunosuppression, Yes   7 (8.5)   5 (31.2) < 0.01
Pathological variables
Differentiation, n (%) 
  Good 
  Moderate
  Poor 
26 (31)
50 (59.5)
  8 (9.5)
  2 (11.1)
13 (72.2)
  3 (16.7)
NS
Tumour thickness, > 6 mm, n (%) 23 (28)   9 (56.3) 0.041
Clark level ≥ 4, n (%) 63 (75.9) 16 (100) 0.037
Perineural invasion, Yes, n (%) 5 (6)   4 (22.2) 0.049
Nerve diameter ≥ 0.1 mm, n (%) 3 (3.6)   4 (22.2) 0.017
Vascular invasion, Yes, n (%) 1 (1.2)   1 (5.6) NS
Desmoplasia, Yes, n (%) 1 (1.2)   3 (16.7) 0.02
Budding, Yes, n (%) 36 (42.9) 16 (88.9) < 0.01
Fibrosis burden, median (IQR)   0 (0;125) 155 (100;200) < 0.01
Staging systems, n (%)
TNM (AJCC-8)
  pT1
  pT2
  pT3
  pT4
33 (40.2)
19 (23.2)
29 (35.4)
  1 (1.2)
  4 (23.5)
  1 (5.9)
10 (58.8)
  2 (11.8)
0.02
TNM (Brigham)
  1
  2a
  2b
  3
32 (39.5)
38 (46.9)
  9 (11.1)
  2 (2.5)
  3 (17.6)
  8 (47.1)
  4 (23.5)
  2 (11.8)
NS
AJCC-8 and Brigham’s staging could not be performed in 3 and 4 cases, respectively 
due to missing values.
IQR: interquartile range.
variate analysis, as well as a strong correlation between 
the myxoid fibrotic pattern and the risk of metastasis in 
the multivariate analysis. The pattern of fibrosis may be 
relevant to the prognosis of epithelial tumours. In this 
regard, most oral SCC (OSCCs) exhibit two main pat-
terns: “spindle” (arranged in rows of few cells around 
the neoplastic islands) and “network” (occupying the 
entire tumour stroma). The latter has apparently been 
linked to aggressive forms of OSCC (29, 30). Similarly, 
a myxoid reaction pattern, or so­called immature fibrotic 
reaction pattern, has been associated with bad prognoses 
in colorectal cancer (17, 18, 25, 26). Although a myxoid 
pattern surrounded by an intense inflammatory infiltrate 
can be found in NMSCC, we have observed that myxoid 
stromal changes in the invasive tumoural front, together 
with the absence of inflammatory cells, is highly specific 
for metastasizing cSCC. The relatively low sensitivity 
of this pattern in MSCC may be due to its presence in 
small, unnoticed areas. These foci may correspond to 
areas where a fibrotic/myxoid reaction inhibits the im-
mune response (“immune response sanctuary”), thus 
favouring the metastatic process. We found this pattern 
to be strongly associated with budding, which is also 
linked to a higher metastatic risk (7, 8, 31). Both budding 
and a myxoid stroma are transitory phenotypes that ap-
pear in the tumour invasive front. CAFs­secreted TGFβ 
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ronment surrounding these cells that plays a role in bad 
prognoses. If our results are confirmed in further studies, 
the pattern of peritumoural fibrosis should be weighed 
as an additional factor to consider in histopathological 
assessments of cSCC with a prognostic value. 
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